Banner Mobile

Clinical Trial Tuberculosis (TB) Testing

Specialized TB testing capabilities to address the research challenges in the field of TB

Due to the complexity of tuberculosis (TB) studies, we understand that when testing and data are managed in a harmonized fashion by a qualified central laboratory, this allows for seamless comparison across all sites. Q2 Solutions has an affiliate laboratory with specialized clinical trial TB testing capabilities located in Pretoria, South Africa. This lab provides state-of-the-art technologies, quality management systems, capacity, and high-quality infrastructure to address the full spectrum of your tuberculosis testing needs.

Affiliate Laboratory in Pretoria, South Africa
  • Full-service laboratory with dedicated Biosafety Level 3 TB lab
  • All TB testing in one facility
  • Only centralized lab in Africa
  • First CAP accredited lab on the African continent
  • Only CAP accredited centralized lab in Africa with full spectrum testing capabilities
  • Global laboratory network to support multi-regional trials
  • Experienced and knowledgeable logistics team
  • NGSP Level 1 laboratory certification
  • CDC Lipids Standardization Program
  • GCP and privacy awareness
pretoria-south-africa
Tuberculosis Testing Methods
Standard Assays
Acid-Fast Bacilli (AFB) Smear
Culture, Identification, and Susceptibility (1st and 2nd line)
by BD MGIT™ system and LJ medium
HAINs assays – Genotypic drug resistance
(MTBDRplus/MTBDR-sl) and Speciation (CM/AS test)
Minimum Inhabitory Concetrations (MIC)
Determination Culture based (Liquid/Solid media)
Mycobacterium Tuberculosis Detection by GeneXpert® TB Test
QuantiFERON® – TB Gold

  

Custom Assay Development and Validation
New Drug Susceptibility Testing – Culture based (Liquid/Solid media)
Sputum TB Plate Quantitative Culture – Serial dilution with plate based growth

Related Thought Leaders Insights


Vaccine Laboratory Services

Q2 Solutions vaccine laboratory services are supported by global, comprehensive central laboratory services to meet your development needs across the entire vaccine development life cycle. View our...

Zika Vaccine Research: Complex Steps Toward a Critical Need

Outbreaks of Zika virus have been reported in several areas including tropical Africa, Southeast Asia and the Pacific Islands. This infectious disease can lead to microcephaly and other severe fetal...

Keeping Up with the Flu: Advances in seasonal influenza vaccine development

Successful seasonal flu vaccine development depends on protecting the world's population against the top 3-4 strains that are expected to be in circulation for the flu season. Keeping track of the...